Acceptance and adherence of oral endocrine therapy in women with metastatic breast cancer: Exacampania group study

Breast Journal

Volumn 21, Issue 3, 2015, Pages 326-328

  Addeo, Raffaele ^a   Iodice, Patrizia ^a   Maiorino, Luigi ^b   Febbraro, Antonio ^c   Incoronato, Pasquale ^d   Pisano, Agata ^e   Bianco, Maddalena ^f   Mabilia, Roberto ^f   Riccardi, Ferdinando ^g   Del Prete, Salvatore ^a  

^a SAN GIOVANNI DI DIO HOSPITAL   (Italy)

^b San Gennaro Hospital   (Italy)

^c FATEBENEFRATELLI HOSPITAL   (Italy)

^d SELEX SI   (Italy)

^e ASLNA2 NORD   (Italy)

^f AORN Cardarelli ^*  (Italy)

^g CARDARELLI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; ESTROGEN RECEPTOR; EXAMESTANE; HORMONE; PROGESTERONE RECEPTOR; TAMOXIFEN; UNCLASSIFIED DRUG; ANDROSTANE DERIVATIVE; EXEMESTANE;

BREAST METASTASIS; CANCER HORMONE THERAPY; HUMAN; LETTER; PATIENT COMPLIANCE; AGED; BREAST NEOPLASMS; CLINICAL TRIAL; FEMALE; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PATHOLOGY;

ADMINISTRATION, ORAL; AGED; ANDROSTADIENES; AROMATASE INHIBITORS; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; PATIENT COMPLIANCE;

EID: 84928213046     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/tbj.12409     Document Type: Letter

References (6)

1. Cardoso F, Fallowfield L, Costa A, Castiglione M, Senkus E,. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2011; 22: vi25-30.
2. Chumsri S, Howes T, Bao T, Sabnis G, Brodie A,. Aromatase, Aromatase inhibitors, and breast cancer. J Steroid Biochem Mol Biol 2011; 125: 13-22.
3. Bertelli G, Gangadhara S,. Examestane in postmenopausal women with early or advanced breast cancer: a review. Expert Opin Pharmacother 2010; 11: 1933-42.
4. Osterberg L, Blaschke T,. Adherence to medication. NEJM 2005; 353: 487-97.
5. Ziller V, Kalder M, Albert US, et al,. Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer. Ann Oncol 2009; 20: 431-6.
6. Hershman DL, Shao T, Kushi LH,. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 2011; 126: 529-37.